Tumour-infiltrating lymphocytes (TILs) as a predictor of response to neadjuvant chemotherapy in breast cancer

被引：0
|
作者：
Hernandez Leon, L. [1 ]
Tapia Melendo, G. [1 ]
Castello Fernandez, E. [1 ]
Sanhueza, T. V. [1 ]
Marginet Flinch, R. [1 ]
Martin Cespedes, M. [1 ]
Quiroga Garcia, V. [1 ]
Margeli Vila, M. [1 ]
机构：
[1] HUGTiP, Inst Catala Salut, Dept Pathol, Badalona, Spain
来源：
VIRCHOWS ARCHIV | 2018年 / 473卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-040
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer
    Truntzer, Caroline
    Isambert, Nicolas
    Arnould, Laurent
    Ladoire, Sylvain
    Ghiringhelli, Francois
    EUROPEAN JOURNAL OF CANCER, 2019, 120 : 97 - 106
  • [22] Prediction of the treatment response to eribulin chemotherapy in breast cancer using tumor-infiltrating lymphocytes (TILs)
    Shinichiro, Kashiwagi
    Asano, Yuka
    Goto, Wataru
    Kurata, Kento
    Morisaki, Tamami
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tanaka, Sayaka
    Ohsawa, Masahiko
    Ohira, Masaichi
    Hirakawa, Kosei
    CANCER RESEARCH, 2016, 76
  • [23] Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients
    Schueler, Kathleen
    Bethmann, Daniel
    Kaufhold, Sandy
    Hartung, Carolin
    Stueckrath, Kathrin
    Lantzsch, Tilmann
    Uleer, Christoph
    Hanf, Volker
    Peschel, Susanne
    John, Jutta
    Poehler, Marleen
    Buchmann, Jorg
    Buerrig, Karl-Friedrich
    Weigert, Edith
    Thomssen, Christoph
    Kantelhardt, Eva Johanna
    Vetter, Martina
    DIAGNOSTICS, 2022, 12 (10)
  • [24] Evaluation of stromal tumour-infiltrating lymphocytes (TILs) in breast cancer by Dynamic contrast - enhanced magnetic resonance (DCE-MR) imaging
    De Lisa, M.
    Pistelli, M.
    Giampieri, R.
    Macchini, M.
    Ponzani, M.
    Giuseppetti, G. M.
    Santinelli, A.
    Bastianelli, L.
    Ballatore, Z.
    Battelli, N.
    Berardi, R.
    ANNALS OF ONCOLOGY, 2017, 28 : 24 - +
  • [25] Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Takada, Koji
    Takahashi, Katsuyuki
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tomita, Shuhei
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    PLOS ONE, 2017, 12 (02):
  • [26] The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer
    Liu, Yanbin
    Liu, Zhenjiang
    Yang, Yixiao
    Cui, Jun
    Sun, Jingwei
    Liu, Yarong
    BRITISH JOURNAL OF CANCER, 2023, 129 (07) : 1041 - 1049
  • [27] Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy
    de Boo, Leonora
    Cimino-Mathews, Ashley
    Lubeck, Yoni
    Daletzakis, Antonios
    Opdam, Mark
    Sanders, Joyce
    Hooijberg, Erik
    van Rossum, Annelot
    Loncova, Zuzana
    Rieder, Dietmar
    Trajanoski, Zlatko
    Vollebergh, Marieke
    Sobral-Leite, Marcelo
    van de Vijver, Koen
    Broeks, Annegien
    van der Wiel, Rianne
    van Tinteren, Harm
    Linn, Sabine
    Horlings, Hugo Mark
    Kok, Marleen
    EUROPEAN JOURNAL OF CANCER, 2020, 127 : 240 - 250
  • [28] Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
    Lee, Nayoung
    Zakka, Labib R.
    Mihm, Martin C., Jr.
    Schatton, Tobias
    PATHOLOGY, 2016, 48 (02) : 177 - 187
  • [29] The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer
    Yanbin Liu
    Zhenjiang Liu
    Yixiao Yang
    Jun Cui
    Jingwei Sun
    Yarong Liu
    British Journal of Cancer, 2023, 129 : 1041 - 1049
  • [30] Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
    Balermpas, P.
    Michel, Y.
    Wagenblast, J.
    Seitz, O.
    Weiss, C.
    Roedel, F.
    Roedel, C.
    Fokas, E.
    BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 501 - 509
12345